Literature DB >> 29723605

Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease.

Ping-Yue Pan1, Yingbo Zhu2, Yuan Shen2, Zhenyu Yue3.   

Abstract

Parkinson's disease (PD) is a debilitating neurodegenerative disorder that profoundly affects one's motor functions. The disease is characterized pathologically by denervation of dopaminergic (DAergic) nigrostriatal terminal and degeneration of DAergic neurons in the substantia nigra par compacta (SNpc); however, the precise molecular mechanism underlying disease pathogenesis remains poorly understood. Animal studies in both toxin-induced and genetic PD models suggest that presynaptic impairments may underlie the early stage of DA depletion and neurodegeneration (reviewed in Schirinzi, T., et al. 2016). Supporting this notion, human genetic studies and genomic analysis have identified an increasing number of PD risk variants that are associated with synaptic vesicle (SV) trafficking, regulation of synaptic function and autophagy/lysosomal system (Chang, D., et al. 2017, reviewed in Trinh, J. & Farrer, M. 2013; Singleton, A.B., et al. 2013). Although the precise mechanism for autophagy regulation in neurons is currently unclear, many studies demonstrate that autophagosomes form at the presynaptic terminal (Maday, S. & Holzbaur, E.L. 2014; Vanhauwaert, R., et al. 2017; reviewed in Yue, Z. 2007). Growing evidence has revealed overlapping genes involved in both SV recycling and autophagy, suggesting that the two membrane trafficking processes are inter-connected. Here we will review emergent evidence linking SV endocytic genes and autophagy genes at the presynaptic terminal. We will discuss their potential relevance to PD pathogenesis.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Autophagy; Endophilin; LRRK2; Parkinson's disease; Synaptic vesicle; Synaptojanin; a-synuclein

Mesh:

Year:  2018        PMID: 29723605     DOI: 10.1016/j.nbd.2018.04.020

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  11 in total

1.  Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice.

Authors:  Ping-Yue Pan; Patricia Sheehan; Qian Wang; Xinyu Zhu; Yuanxi Zhang; Insup Choi; Xianting Li; Jacqueline Saenz; Justin Zhu; Jing Wang; Farida El Gaamouch; Li Zhu; Dongming Cai; Zhenyu Yue
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 2.  Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?

Authors:  Yvette C Wong; Kelvin Luk; Kerry Purtell; Samuel Burke Nanni; A Jon Stoessl; Louis-Eric Trudeau; Zhenyu Yue; Dimitri Krainc; Wolfgang Oertel; Jose A Obeso; Laura A Volpicelli-Daley
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 4.  Dopaminergic Axons: Key Recitalists in Parkinson's Disease.

Authors:  Abhishek Kumar Mishra; Anubhuti Dixit
Journal:  Neurochem Res       Date:  2021-10-12       Impact factor: 3.996

5.  Synergistic Neuroprotective Effect of Endogenously-Produced Hydroxytyrosol and Synaptic Vesicle Proteins on Pheochromocytoma Cell Line Against Salsolinol.

Authors:  Robina Manzoor; Aamir Rasool; Maqbool Ahmed; Ullah Kaleem; Lucienne Nneoma Duru; Hong Ma; Yulin Deng
Journal:  Molecules       Date:  2020-04-08       Impact factor: 4.411

Review 6.  Retromer in Synaptic Function and Pathology.

Authors:  Lennart Brodin; Oleg Shupliakov
Journal:  Front Synaptic Neurosci       Date:  2018-10-24

7.  Noncanonical Roles of hα-syn (A53T) in the Pathogenesis of Parkinson's Disease: Synaptic Pathology and Neuronal Aging.

Authors:  Qing-Jun Wang; An-Di Chen; Hai-Chao Chen; Dong-Xin Wang; Yi-Ting Cai; Jie Yin; Yu-Hong Jing; Li-Ping Gao
Journal:  Neural Plast       Date:  2020-03-21       Impact factor: 3.599

8.  Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein.

Authors:  Charlotte F Brzozowski; Baraa A Hijaz; Vijay Singh; Nolwazi Z Gcwensa; Kaela Kelly; Edward S Boyden; Andrew B West; Deblina Sarkar; Laura A Volpicelli-Daley
Journal:  Acta Neuropathol Commun       Date:  2021-11-08       Impact factor: 7.801

9.  Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson's Disease.

Authors:  Shaoqi Yan; Xinbing Wei; Wencheng Jian; Yue Qin; Jia Liu; Shaowei Zhu; Fan Jiang; Haiyan Lou; Bin Zhang
Journal:  Front Aging Neurosci       Date:  2020-03-31       Impact factor: 5.750

Review 10.  The Emerging Role of the Lysosome in Parkinson's Disease.

Authors:  Alba Navarro-Romero; Marta Montpeyó; Marta Martinez-Vicente
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.